The Resource Talking back to prozac : what doctors won't tell you about today's most controversial drug, Peter R. Breggin and Ginger Ross Breggin

Talking back to prozac : what doctors won't tell you about today's most controversial drug, Peter R. Breggin and Ginger Ross Breggin

Label
Talking back to prozac : what doctors won't tell you about today's most controversial drug
Title
Talking back to prozac
Title remainder
what doctors won't tell you about today's most controversial drug
Statement of responsibility
Peter R. Breggin and Ginger Ross Breggin
Creator
Contributor
Subject
Language
eng
Summary
  • Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro-Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain - with few or no side effects. But is the reality quite different? At what price do we buy Prozac-induced euphoria and a shiny new personality?
  • Psychiatrist Peter Breggin, M.D., and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works
  • And they take a hard look at the real story behind today's most controversial drug: the fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval; the difficulty Prozac's manufacturer had in proving its effectiveness during these tests; the information on side effects that the FDA failed to include in its final labeling requirements; how Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine; the dangers of possible Prozac addiction and abuse; the seriousness and frequency of Prozac's side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm; the growing evidence that Prozac can cause violence and suicide; and the social and workplace implications of using the drug not to cure depression but to change personality and enhance performance
  • Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it
Cataloging source
DLC
http://library.link/vocab/creatorDate
1936-
http://library.link/vocab/creatorName
Breggin, Peter Roger
Dewey number
615/.78
Illustrations
illustrations
Index
index present
LC call number
RC483.5.F55
LC item number
B75 1994
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
Breggin, Ginger Ross
http://library.link/vocab/subjectName
  • Fluoxetine
  • Fluoxetine
  • Fluoxetine
  • Personality change
  • Antipsychiatry
  • Fluoxetine
  • Personality Disorders
  • Psychofarmaca
Label
Talking back to prozac : what doctors won't tell you about today's most controversial drug, Peter R. Breggin and Ginger Ross Breggin
Link
Instantiates
Publication
Bibliography note
Includes bibliographical references (p. [241]-263) and index
Contents
Should we listen to Prozac? -- A primer on how Prozac is supposed to work -- The real story behind Prozac's approval by the FDA -- The real story behind Prozac's side effects -- Drug addiction and abuse: a comparison between Prozac and amphetamines -- Drug-induced paranoia, violence, depression, and suicide: a comparison between Prozac and amphetamines -- Can Prozac cause violence and suicide? what survivors, independent researchers, and the FDA have to say -- Pushing drugs in America: the long financial tentacles of Eli Lilly -- How and why to stop taking psychiatric drugs -- Understanding and overcoming depression
Edition
1st ed.
Extent
1 online resource (xiv, 273 pages
Form of item
online
Other physical details
illustrations)
Specific material designation
remote
System control number
(OCoLC)1036892515
Label
Talking back to prozac : what doctors won't tell you about today's most controversial drug, Peter R. Breggin and Ginger Ross Breggin
Link
Publication
Bibliography note
Includes bibliographical references (p. [241]-263) and index
Contents
Should we listen to Prozac? -- A primer on how Prozac is supposed to work -- The real story behind Prozac's approval by the FDA -- The real story behind Prozac's side effects -- Drug addiction and abuse: a comparison between Prozac and amphetamines -- Drug-induced paranoia, violence, depression, and suicide: a comparison between Prozac and amphetamines -- Can Prozac cause violence and suicide? what survivors, independent researchers, and the FDA have to say -- Pushing drugs in America: the long financial tentacles of Eli Lilly -- How and why to stop taking psychiatric drugs -- Understanding and overcoming depression
Edition
1st ed.
Extent
1 online resource (xiv, 273 pages
Form of item
online
Other physical details
illustrations)
Specific material designation
remote
System control number
(OCoLC)1036892515

Library Locations

  • Internet ArchiveBorrow it
    300 Funston Ave, San Francisco, CA, 94118, US
    37.7823215 -122.4716373

Library Links

Processing Feedback ...